Blood Cancer Research
The focus of the Blood Cancer Research Group is to understand the lymphoma tumour microenvironment to assist in the identification of patients at high-risk of responding poorly to conventional therapies. It will also enable the design of novel immunotherapeutic strategies that are less toxic and more effective.
The Research Group has a strong emphasis on patient material which it obtains from international and national clinical collaborators. Lymphomas studied include Hodgkin Lymphoma, Post Transplant Lymphoproliferative Disorder, Diffuse Large B-cell Lymphoma, Follicular Lymphoma and Epstein-Barr virus associated lymphomas.
The Group utilise a broad range of approaches including genomics, molecular techniques and functional immunoassays and studies have resulted in large national investigator-led clinical trials run through the Australasian Leukaemia and Lymphoma Group.
Current funding sources include the NHMRC, MRFF and Children’s Hospital Foundation. The Group gratefully receives support to undertake work for the Mark Coghlan Immunobiology of Epstein-Barr Virus Positive Hodgkin Lymphoma Project.
Group Leader
Group members
Professor Maher Gandhi is supported by group members and student researchers:
- Dr Soi Law
- Isabelle Putt
- Dr Joshua Tobin
- Muhammed B Sabdia
- Hennes Tsang
- Anna Pilaar
